Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 10 min ago
PreprintAll rights reservedbioRxiv

Receptor-guided engineering of oncolytic vaccinia creates a synthetic support niche for off-the-shelf NK cell therapy

  • R. Rezaei
  • Z. Gan
  • N. Akeem Akilimali
  • J. Reff
  • M. Lin
  • Y. Xiao
  • K. Parikh
  • D. Vithlani
  • B. Valentic
  • A. A. Shestov
  • U. Uslu
  • T. Azad
3 more authors
  • R. S. OConnor
  • C. H. June
  • N. C. Sheppard1
  1. 1University of Pennsylvania
Read full textPDFDOICite

Related

  1. Interleukin-21 expressing oncolytic vaccinia virus elicits systemic anti-tumor immune response and synergizes with immunotherapies
    Rong Zhang, Tingting Wang, Yu Wang +7
    Molecular Therapy: OncologyPeer-reviewedCC BYFull textGenetics & genomicsDOAJEurope PMCPMC
  2. Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies
    Rui Li, Xiafei Liu, Xiliang Cong +4
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  3. Synthetic genome shuffling of poxviruses in yeast generates novel poxvirus candidates with potential oncolytic properties.
    Aimeric Agaoua, Camille Rey, Julie Hortelano +3
    Frontiers in bioengineering and biotechnologyPeer-reviewedCC BYFull textGenetics & genomicsEurope PMCPMC
  4. Advances in plant metabolic engineering through synthetic biology
    Hind Alsuwat, Derry Alvarez, Salim Al-Babili
    Frontiers in plant sciencePeer-reviewedCC BYFull textPlant biologyEurope PMC
  5. Synthetic microbial communities for engineering climate‐smart biofertilizers
    Yan Liu, Yuehua Chen, Yanxue Yu +7
    iMetaPeer-reviewedCC BY7 citedPlant biologyOpenAlex

Cite

BibTeXRIS
BibTeX
@misc{rezaei2026receptorguided,
  title = {{Receptor-guided engineering of oncolytic vaccinia creates a synthetic support niche for off-the-shelf NK cell therapy}},
  author = {R. Rezaei and Z. Gan and N. Akeem Akilimali and J. Reff and M. Lin and Y. Xiao and K. Parikh and D. Vithlani and B. Valentic and A. A. Shestov and U. Uslu and T. Azad and R. S. OConnor and C. H. June and N. C. Sheppard},
  howpublished = {bioRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.06.764990},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.06.764990v1},
}
RIS
TY  - UNPB
TI  - Receptor-guided engineering of oncolytic vaccinia creates a synthetic support niche for off-the-shelf NK cell therapy
AU  - R. Rezaei
AU  - Z. Gan
AU  - N. Akeem Akilimali
AU  - J. Reff
AU  - M. Lin
AU  - Y. Xiao
AU  - K. Parikh
AU  - D. Vithlani
AU  - B. Valentic
AU  - A. A. Shestov
AU  - U. Uslu
AU  - T. Azad
AU  - R. S. OConnor
AU  - C. H. June
AU  - N. C. Sheppard
PY  - 2026
DA  - 2026/11/06
PB  - bioRxiv
DO  - 10.64898/2026.11.06.764990
UR  - https://www.biorxiv.org/content/10.64898/2026.11.06.764990v1
ER  -